Development and Validation of a Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates.

Mark N Belkin, Richard Dorent, Matthew M Churpek, Kiran K Khush, Kevin C Zhang, William F Parker, Nikhil Narang, Carine Jasseron, Kevin A Lazenby, Jonathan Grinstein, Anoop Mayampurath

Journal: JAMA 2024;331(6):500-509

PMID: 38349372

Abstract

IMPORTANCE

The US heart allocation system prioritizes medically urgent candidates with a high risk of dying without transplant. The current therapy-based 6-status system is susceptible to manipulation and has limited rank ordering ability.

OBJECTIVE

To develop and validate a candidate risk score that incorporates current clinical, laboratory, and hemodynamic data.

DESIGN, SETTING, AND PARTICIPANTS

A registry-based observational study of adult heart transplant candidates (aged ≥18 years) from the US heart allocation system listed between January 1, 2019, and December 31, 2022, split by center into training (70%) and test (30%) datasets. Adult candidates were listed between January 1, 2019, and December 31, 2022.

MAIN OUTCOMES AND MEASURES

A US candidate risk score (US-CRS) model was developed by adding a predefined set of predictors to the current French Candidate Risk Score (French-CRS) model. Sensitivity analyses were performed, which included intra-aortic balloon pumps (IABP) and percutaneous ventricular assist devices (VAD) in the definition of short-term mechanical circulatory support (MCS) for the US-CRS. Performance of the US-CRS model, French-CRS model, and 6-status model in the test dataset was evaluated by time-dependent area under the receiver operating characteristic curve (AUC) for death without transplant within 6 weeks and overall survival concordance (c-index) with integrated AUC.

RESULTS

A total of 16 905 adult heart transplant candidates were listed (mean [SD] age, 53 [13] years; 73% male; 58% White); 796 patients (4.7%) died without a transplant. The final US-CRS contained time-varying short-term MCS (ventricular assist-extracorporeal membrane oxygenation or temporary surgical VAD), the log of bilirubin, estimated glomerular filtration rate, the log of B-type natriuretic peptide, albumin, sodium, and durable left ventricular assist device. In the test dataset, the AUC for death within 6 weeks of listing for the US-CRS model was 0.79 (95% CI, 0.75-0.83), for the French-CRS model was 0.72 (95% CI, 0.67-0.76), and 6-status model was 0.68 (95% CI, 0.62-0.73). Overall c-index for the US-CRS model was 0.76 (95% CI, 0.73-0.80), for the French-CRS model was 0.69 (95% CI, 0.65-0.73), and 6-status model was 0.67 (95% CI, 0.63-0.71). Classifying IABP and percutaneous VAD as short-term MCS reduced the effect size by 54%.

CONCLUSIONS AND RELEVANCE

In this registry-based study of US heart transplant candidates, a continuous multivariable allocation score outperformed the 6-status system in rank ordering heart transplant candidates by medical urgency and may be useful for the medical urgency component of heart allocation.

Address: Department of Medicine, University of Chicago, Chicago, Illinois.; Advocate Heart Institute, Advocate Christ Medical Center, Oak Lawn, Illinois.; Department of Medicine, University of Illinois-Chicago.; Agence de la Biomédecine, Direction Prélèvement Greffe Organes-Tissus, Saint-Denis La Plaine, France.; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison.; Department of Medicine, University of Wisconsin, Madison.; Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, California.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Public Health Sciences, University of Chicago, Chicago, Illinois.; MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, Illinois.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.